Laflamme- Chapter 3 (Heart Failure) Flashcards

1
Q

What dose of Bumetanide is equivalent to 40mg Lasix?

A

Bumetanide 1mg daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is Spironolactone dosing if CrCl 30-49?

A

25mg daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are three contraindications to ACEi/ARB use?

A
  • Angioedema
  • RAS
  • Pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are contraindications for beta blockers?

A
  • Active HF
  • Shock
  • Hypoperfusion
  • Asthma
  • PR > 240 msec
  • 2nd or 3rd deg heart block
  • Severe PAD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are 2 contraindications for MRA use?

A
  • Hyper K > 5.0

- GFR < 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What part of the nephron does MRA work on?

A

-Collecting tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name 5 mechanisms for Diuretic resistance

A
  • Post sodium excretion stimulation of the RAAS
  • Decreased absorption due to edema of the intestinal wall
  • Decreased CO and getting diuretic to kidney
  • Hypertrophy of distal tubule
  • Cardiorenal syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does Digoxin work?

A

Inhibits the Na-K-ATPase pump which increased intramyocyte Ca (increases inotropy) and increases vagal tone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is serum target level for digoxin?

A

-0.5-0.9 ng/ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name 12 medications that increase Digoxin levels

A
  • Amiodarone
  • Verapamil
  • Nifedipine
  • Carvedilol
  • Captopril
  • Propafenone
  • Quinidine
  • Spironolactone
  • Cyclosporine
  • Macrolides
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What % of HF patients have Central Sleep Apnea?

A

40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Cheyne-Stokes breathing?

A
  • Hyperventilation followed by apnea (>10 seconds) with no ventilatory effort
  • This is associated with pulmonary congestion and is an independent RF for mortality.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

-What is the treatment for Cheyne Stokes breathing?

A
  • Optimize HF therapy

- There is no benefit for CPAP (CANPAP) or Servo-Ventilation (SERVE HF, increased mortality)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What % of HF patients have OSA?

A

-10 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 6 echo features of diastolic dysfunction?

A
  • E/e prime > 15
  • E/A inversion during valsalva
  • Diastolic dominance of PV inflow
  • Prolonged reversal of flow in PV during atrial kick
  • LA dilatation
  • Pulmonary hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the MOA of Nitroglycerin?

A
  • NO intracellular -> cGMP in smooth muscle cells -> leads to Vasodilation
  • Venous vasodilator > Arterial/Coronary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the MOA of Nitroprusside?

A

-Balanced vasodilator with a shorter have life than nitroglycerin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the unique risk of Nitroprusside?

A

-Cyanide toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does Nesiritide work?

A
  • Recombinant BNP

- No benefit in ASCEND HF, ROSE AHF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the MOA of Dobutamine?

A

-Beta 1 and Beta 2 agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the MOA of Dopamine?

A
  • Positive inotrope and vasopressor
  • Vasodilator at low doses
  • It is a NE precursor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the MOA of Milrinone?

A

-PDE3 Inhibitor -> increased intracellular CAMP -> Increased intracellular Ca2+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are hemodynamic targets for the following during HF management for the following: LCWP, CVP, BP, SVO2, SVR, CI

A
  • Wedge < 18
  • CVP < 8
  • MAP > 60
  • SVO2 > 70%
  • SVR 1000-1200
  • CI 2.2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How much do the following increase CO? IABP, Impella, ECMO

A
  • IABP: 10-15%
  • Impella: 2.5-5L/min
  • ECMO: 5 L/min
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

When to list for transplant on basis of CPX?

A

-14 (12 if on BB)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What cold ischemia time is required for a Heart donor?

A

-Cold ischemia time < 4h

27
Q

What two cardiac investigations do donors need?

A
  • TTE

- Cath (depending on risk)

28
Q

What PRA level indicates that patient is sensitized?

A

10%

29
Q

What is management for patients who are PRA sensitized?

A

-IVIG, Rituximab, Plasmapheresis

30
Q

Name 4 hemodynamic contraindications to transplant?

A
  • PVR > 3 WU
  • TPG (mPAP - Wedge) > 15
  • PVR > 2.5 WU in response to pharmacologic challenge while maintaining SBP > 85mmHg
  • PVR Index (TPG/CI) > 6
31
Q

Name 12 non-hemodynamic contraindications to transplant?

A
  • Irreversible renal function GFR < 30
  • Irreversible liver dsiease
  • Pre-existing cancer
  • Active infection
  • Clinically severe CVD
  • PAD which limit rehab
  • DM with target organ damage or poor control Hba1c > 7.5%
  • Non compliance
  • Active substance use
  • Obesity > 35 BMI
  • Age > 70 y.o
  • Frailty
32
Q

What are the stages of the Priority Allocation system?

A

1) other
2) Inpatient or outpatient on inotropes
3) Incomplicated VAD, inhospital on inotropes, arrhytmhmia
4) Dependent on MCS

33
Q

What two medications can be given for transplant induction therapy?

A
  • Anti IL2 receptor antibodies (Basiliximab)

- rATG (antithymocyte immunoglobulins)

34
Q

How long to continue corticosteroids?

A

6 months then tapering

35
Q

How do CNI’s work?

A

-decrease T cell activation

36
Q

How do purine synthesis inhibitors work? (AZA, MMF)

A

-Inhibit Tcell and Bcell proliferation

37
Q

When would you use an MTOR inhibitor? (Sirolimus)

A
  • Alternative to CNI in presence of renal toxicity

- Decreases the risk of CAV, treatment of CAV

38
Q

What is the main risk of MTOR inhibitor?

A

Impaired wound healing

39
Q

What is the mechanism for cellular rejection?

A

-Lymphocyte infiltrates weeks to years post transplant

40
Q

What % of Cellular rejection occurs in the first year post transplant?

A

40%

41
Q

How to monitor for Cellular rejection?

A

-Weekly biopsy for 6 weeks, then monthly for 6 months, then every 3 months for 2 years

42
Q

What are 4 risk factors for cellular rejection?

A
  • Young
  • Female
  • CMV+
  • HLA incompatibility
43
Q

How to treat cellular rejection?

A

-Corticosteroids, intensify immunosuppression

44
Q

How do you stage Cellular rejection?

A

OR: Absence of rejection

1R: < 1 zon of myocyte injury from lymphocytic infiltration

2R: 2 or more zones

3R: Multiple zones

45
Q

What is Humoral rejection?

A

-Anti donor HLA antibodies form, absence of lymphocytic infiltrate

46
Q

What does Humoral rejection look like on echo? Biopsy?

A
  • Echo: Graft dysfunction, wall thickening (edema)

- Biospy: Capillary endothelial congestion, macrophages in capillaries, no lymphocytes

47
Q

What is the prevalence of CAV at 10 years?

A

50%

48
Q

What is the hallmark of CAV on cath/imaging/biopsy?

A

Diffuse concentric neointimal proliferation

49
Q

Why do patients with CAV have less angina than those with native CAD

A

No angina due to denervation

50
Q

What are 6 RFs for CAV?

A
  • All traditional CAD RFs
  • Rejection history
  • HLA incomptability
  • Graft ischemia time
  • Donor age
  • CMV+
51
Q

How to treat CAV?

A
  • Statins
  • ASA
  • Control RFs
  • MTor inhibitor
  • PCI (possible)
  • Re transplant
52
Q

What three microbes need prophylaxis? For how long?

A

-6-12 months post transplant

CMV: Acyclovir/Valganciclovir

PJP: TMP/SMX

Toxoplasmosis: Voriconazole

53
Q

What is risk of malignancy at 10 years? What are 3 most common?

A
  • 30%

- Lymphoma, Skin cancer, Solid organs

54
Q

What is mean survival post transplant?

A

-10 years

55
Q

Describe the Intermacs Profile?

A

Used to describe time to mechanical support

1) Crashing and burning (hours)
2) Progressive Decline on Inotropes (days)
3) Stable but Inotrope dependent (weeks)
4) Recurrent HF (week to months)
5) Exertion Intolerant (variable)
6) Exertion limited (variable)
7) NYHA III (not candidate)

56
Q

Name 9 factors that predict post LVAD in hospital survival?

A
  • Plt < 148
  • Albumin < 33
  • INR > 1.1
  • Vasodilator therapy
  • AST > 45
  • mPAP < 25
  • AST > 45
  • Hct < .34
  • BUN < 51
  • Absence of IV inotrope
57
Q

How should you titrate speed according to echo? (3)

A
  • Aortic valve opening every 3 cycles
  • Position of IV septum
  • LV and RV chambers
58
Q

What is anticoagulation for LVAD?

A

-INR 2-3, ASA 81mg daily

59
Q

What should BP target be in LVAD?

A

MAP 60-80mmhg

60
Q

Name 10 complications of LVADs?

A
  • RV failure
  • Fusion of Aortic valve leaflets
  • Bleeding (vWF deficiency)
  • Hemolysis
  • HIT
  • Stroke
  • Infection
  • Break down
  • Device thrombosis
  • Allosensitization
61
Q

What are 3 indications for Heart Transplant?

A
  • Advanced/Late stage heart failure with unacceptable QoL and high anticipated mortality despite optimal medical therapy
  • Peak VO2 < 14 (< 12 if beta blocker)
  • High anticipated 1 year transplant free mortality by accepted scores ( < 80% 1y survival based on Seattle HF score)
62
Q

What are 4 mechanisms of Cardiorenal syndrome?

A
  • Venous congestion
  • Hypovolemia
  • Ascites
  • Hypoperfusion
  • Medications
63
Q

What are 5 causes of Cardiomyopathy that also cause heart block?

A
  • Myocarditis
  • Amyloidosis
  • Familial CMO (LMNA, SCN5a)
  • Lyme Disease
  • Myotonic Dystrophy